Financing

Transave has completed the following financings:

• $4 million Series A financing in August 2000. This round was led by Techno Venture Management a world leading venture capital investment group in the biotechnology field.
• $14 million Series B financing in December 2002 led by Forbion Capital Partners and Easton Hunt Capital Partners. TVM Capital also participated.
• $40 million Series C Private Financing in February 2006 led by Prospect Venture Partners and Fidelity Biosciences. Additional investments were made by TVM Capital, Forbion Capital Partners and Easton Hunt Capital Partners.
• $35 million Series D financing in March 2008 led by Quaker BioVentures and Bessemer Venture Partners. Additional investments were made by TVM Capital, Prospect Venture Partners, Fidelity Biosciences, Forbion Capital Partners and Easton Hunt Capital Partners.
• $12.5 million venture loan in August 2008 from CIT Healthcare and Compass Horizon Funding Company, part of Horizon Technology Finance LLC.

Transave has recently closed a $35 million Series D private equity financing.